Transplanted Organ Rejection clinical trials at UCSF

1 research study open to eligible people

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
open to eligible people ages 18 years and up
A randomized controlled study to assess the safety and efficacy and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.
San Francisco, California and other locations

Last updated: February 15, 2022